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increases the proliferation and
radioresistance by targeting p21 in human
lung cancer cells
Yiting Tang1†, Yayun Cui2†, Zengpeng Li3†, Zhuqing Jiao4, Yong Zhang5, Yan He6, Guangxia Chen7, Qunyan Zhou8,
Wenjie Wang6, Xifa Zhou1, Judong Luo1* and Shuyu Zhang6*Unfortunately, the original version of this article [1] con-
tained an error. The name of one of the authors was in-
cluded incorrectly and it read “Guangxia Cheng” instead
of “Guangxia Chen”.
The name has been updated in the original article and
is also correctly included in full in this erratum.
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